Advertising Disclosure: This site contains affiliate links. We may earn a commission if you purchase through our links, at no extra cost to you. Learn more
It's hard to scroll social media or watch an awards show without someone speculating about a visibly slimmer public figure. Over the past few years, rapid celebrity weight loss has become one of the most talked-about topics in pop culture — and it's fueled almost entirely by one class of drug.
The trend traces back to GLP-1 receptor agonists — semaglutide (sold as Ozempic for diabetes, Wegovy for weight loss) and tirzepatide (Mounjaro/Zepbound) — originally developed for type 2 diabetes. Their appetite-suppressing side effect turned out to be so pronounced that off-label use for weight loss exploded. Approximately a third of Ozempic prescriptions have been for off-label weight loss rather than diabetes management, and online search interest in semaglutide rose roughly 170% in the US in just the first half of 2023.
Once a handful of public figures began speaking openly about using these medications, media coverage — and public curiosity about who else might be using them — accelerated the trend further. Research published in Aesthetic Surgery Journal found that celebrity endorsements and public discussion of these drugs measurably increased Google search volume for semaglutide products, creating a feedback loop between pop culture and prescription demand.
For decades, discussing weight-loss methods publicly was largely avoided by public figures. A wave of public figures speaking openly about using medication for weight management shifted that — normalizing a conversation that had mostly happened in private.
Clinical trial data shows semaglutide users lost an average of roughly 12.7 kg (about 28 lbs) over 68 weeks compared to placebo — a magnitude of change that's highly visible in photos, which is exactly the kind of before-and-after content that spreads on social media.
As demand exploded, drug shortages followed — a well-documented consequence that made headlines of its own, and drew criticism because it affected diabetic patients who depend on these medications for blood sugar control, not weight loss.
What gets far less coverage is what happens after the trend photo is taken. A systematic review and meta-regression found that, on average, patients regain roughly 60% of lost weight within one year of stopping GLP-1 therapy, with regain trajectories plateauing at around 75% of the original weight lost. A large 2026 Cleveland Clinic real-world study of nearly 8,000 patients found a more mixed picture — many patients who stopped kept most of the weight off by switching medications, restarting treatment, or making lifestyle changes, while roughly half who fully discontinued did regain weight. Nearly three in four people who start these medications for weight loss stop taking them within two years, most commonly due to side effects, cost, or insurance coverage changes.
In other words: for the people whose transformations dominate headlines, the drug is very often an ongoing, indefinite commitment — not a one-time fix.
GLP-1 medications are prescription drugs with real medical uses and real risks, and this article isn't medical advice about whether to use one — that's a conversation for you and your doctor. But if the injection route isn't for you — due to cost, needle aversion, side effects, or simply wanting to try a non-prescription approach first — the underlying goals the trend has made mainstream (better appetite regulation, more stable blood sugar, less reliance on willpower alone) are things a daily supplement approach can also support, just through a different mechanism and typically a much smaller effect size.
Hormovance uses Berberine, Green Tea Extract, and other studied ingredients to support appetite regulation, blood sugar stability, and metabolism — no prescription, no needles.
See How Hormovance Works →Read more about how Hormovance's full ingredient panel is formulated to support these same goals daily.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs; talk to a healthcare provider about whether one is appropriate for you. Hormovance is a dietary supplement, not a GLP-1 receptor agonist, and is not a substitute for prescription medication.